Junliang Hao
Publication Activity (10 Years)
Years Active: 2018-2022
Publications (10 Years): 4
Publications (10 Years): 4
Publications
- Junliang Hao, James Beck, Xin Zhou, Gregory L Lackner, Richard Johnston, Matt Reinhard, Paul Goldsmith, Sean Hollinshead, Veronique Dehlinger, Sandra A Filla, Xu-Shan Wang, Jeffery Richardson, Maria Posada, Mike Mohutsky, Doug Schober, Jason S Katner, Qi Chen, Bingjie Hu, David M Remick, David A Coates, Brian M Mathes, Mai K Hawk, Kjell A Svensson, Erik Hembre
- Qi Chen, Xin Zhou, Jessica Rehmel, James P Steele, Kjell A Svensson, James P Beck, Erik J Hembre, Junliang Hao
- Junliang Hao, James P Beck, John M Schaus, Joseph H Krushinski, Qi Chen, Christopher D Beadle, Paloma Vidal, Matthew R Reinhard, Bruce A Dressman, Steven M Massey, Serge L Boulet, Michael P Cohen, Brian M Watson, David Tupper, Kevin M Gardinier, Jason Myers, Anette M Johansson, Jeffery Richardson, Daniel S Richards, Erik J Hembre, David M Remick, David A Coates, Rajni Miglani Bhardwaj, Benjamin A Diseroad, David Bender, Greg Stephenson, Craig D Wolfangel, Nuria Diaz, Brian G Getman, Xu-Shan Wang, Beverly A Heinz, Jeff W Cramer, Xin Zhou, Deanna L Maren, Julie F Falcone, Rebecca A Wright, Stephen N Mitchell, Guy Carter, Charles R Yang, Robert F Bruns, Kjell A SvenssonSynthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1-((1S,3R)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor. Journal of medicinal chemistry 62 (19) (2019)
- Qi Chen, Joseph D Ho, Sheela Ashok, Michelle C Vargas, Jing Wang, Shane Atwell, Mark Bures, Jeffery M Schkeryantz, James A Monn, Junliang Hao